Ross Wallace is the secretary of the Canadian Biosimilars Forum — an alliance of four companies that have come together to maximize the positive impact of biosimilars on Canadian patients. The forum includes Biogen Canada, Organon Canada, Pfizer Canada and Sandoz Canada. Wallace is also a principal at Santis Health, a public affairs firm focused exclusively on health care and life sciences. In a previous life, he was the director of government affairs at AstraZeneca Canada. He has a master’s in business administration from the University of Toronto and a master’s in public administration from Queen’s University.